600
Participants
Start Date
May 19, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
January 3, 2028
Pelacarsen (TQJ230)
pelacarsen 80mg s.c. monthly
RECRUITING
Capitol Cardiology Associates, Lanham
RECRUITING
Anderson Medical Research, Ft. Washington
RECRUITING
Virginia Heart, Falls Church
RECRUITING
Javara Research, Alexandria
RECRUITING
National Research Institute, Hialeah
RECRUITING
Inpatient Research Clinical LLC, Miami Lakes
RECRUITING
DBC Research USA, Pembroke Pines
RECRUITING
Finlay Medical Research, Miami
RECRUITING
Proactive Clinical Research, Fort Lauderdale
RECRUITING
Excel Medical Clinical Trials LLC, Boca Raton
RECRUITING
Cardiology Partners Clinical Research Institute, Wellington
RECRUITING
Parkway Medical Center, Birmingham
RECRUITING
Apex Cardiology Research Associates of Jackson, Jackson
RECRUITING
Henry Ford Hospital, Detroit
RECRUITING
Aa Mrc Llc, Flint
RECRUITING
Cardiovascular Associates Research, Covington
RECRUITING
Southern Clin Research Clinic, Zachary
RECRUITING
North Hills Medical Research Inc, Bedford
RECRUITING
Angiocardiac Care of Texas PA, Houston
RECRUITING
Biopharma Informatic LLC, Houston
RECRUITING
Biopharma Informatic LLC, Houston
RECRUITING
Clinical Trials of Texas, San Antonio
RECRUITING
AB Clinical Trials, Las Vegas
RECRUITING
Clinical Research of South Nevada, Las Vegas
RECRUITING
National Heart Institute, Beverly Hills
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY